Water Innovate is a technology transfer spin-out from the Cranfield University School of Water Sciences. Through the acquisition, Bluewater Bio will gain immediate access to Water Innovate’s current range of products, already in successful demonstration trials with major global utilities including Severn Trent Plc in the UK. The acquisition includes a five year rolling agreement providing the Bluewater Bio with access to Cranfield’s own ongoing R&D pipeline of advanced wastewater treatment technologies. It is expected that completion of the deal will take place in October.

Daniel Ishag, CEO of Bluewater Bio, said: “This announcement marks a significant point in a pivotal year for Bluewater Bio during which we have continued our growth trajectory as a privately held company. Commercial interest in our proprietary HYBACS technology is growing but we have made no secret of our acquisitive plans. Once the acquisition is complete, we look forward to installing one of our SMART units for ongoing evaluation and demonstration at Cranfield, integrating Water Innovate’s technologies and developing the second generation of our HYBACs system.”